Optimization of cord blood unit sterility testing: impact of dilution, analysis delay, and inhibitory substances

摘要

BACKGROUND Different methods are used by cord blood banks to prepare samples for sterility testing. Suboptimal methods can result in the release of contaminated products. In our organization, samples are prepared by diluting the final product in RPMI‐1640 medium. In this work, we have compared our method with different approaches to verify whether optimization should be sought. STUDY DESIGN AND METHODS Cord blood units (n?=?6 units per bacterial strain) characterized to contain inhibitory substances or not were inoculated (10 colony‐forming units/mL) with Streptococcus agalactiae , Staphylococcus epidermidis , Klebsiella pneumoniae , Escherichia coli , or Bacteroides fragilis . After plasma and red blood cell removal, stem cell concentrates were diluted in RPMI‐1640, thioglycollate, or the unit's plasma. These products, as well as final product, plasma, and red blood cell fractions, were held from 0 to 72 hours at 20 to 24°C before inoculation in culture bottles and detection using the BacT/ALERT 3D system. RESULTS Dilution of cell concentrates in RPMI‐1640 allowed bacterial detection in 93.3% of noninhibitory cord blood samples after a 24‐hour storage period. Thioglycollate medium better promoted bacterial growth in inhibitory cord blood samples that were held for 72 hours before testing (66.7%) compared with RPMI‐1640 (45.0%). Less than 33% of all spiked plasma samples were detected by the BacT/ALERT 3D system. CONCLUSION Diluting cord blood samples in culture medium containing bacterial growth promoting substances is a suitable option for sterility testing, whereas the use of plasma should be proscribed, because it might lead to false‐negative results. Because inhibitory substances affect bacterial growth, inoculation of culture bottles should be done rapidly after sample preparation.